Advertisement

Sodium–Calcium Exchangers of the SLC8 Family in Oligodendrocytes: Functional Properties in Health and Disease

  • Samantha A. Spencer
  • Edna Suárez-Pozos
  • Miguel Escalante
  • Yu Par Myo
  • Babette FussEmail author
Original Paper

Abstract

The solute carrier 8 (SLC8) family of sodium–calcium exchangers (NCXs) functions as an essential regulatory system that couples opposite fluxes of sodium and calcium ions across plasmalemmal membranes. NCXs, thereby, play key roles in maintaining an ion homeostasis that preserves cellular integrity. Hence, alterations in NCX expression and regulation have been found to lead to ionic imbalances that are often associated with intracellular calcium overload and cell death. On the other hand, intracellular calcium has been identified as a key driver for a multitude of downstream signaling events that are crucial for proper functioning of biological systems, thus highlighting the need for a tightly controlled balance. In the CNS, NCXs have been primarily characterized in the context of synaptic transmission and ischemic brain damage. However, a much broader picture is emerging. NCXs are expressed by virtually all cells of the CNS including oligodendrocytes (OLGs), the cells that generate the myelin sheath. With a growing appreciation of dynamic calcium signals in OLGs, NCXs are becoming increasingly recognized for their crucial roles in shaping OLG function under both physiological and pathophysiological conditions. In order to provide a current update, this review focuses on the importance of NCXs in cells of the OLG lineage. More specifically, it provides a brief introduction into plasmalemmal NCXs and their modes of activity, and it discusses the roles of OLG expressed NCXs in regulating CNS myelination and in contributing to CNS pathologies associated with detrimental effects on OLG lineage cells.

Keywords

Oligodendrocyte Myelin Sodium–calcium exchangers Ion homeostasis Signaling 

Notes

Acknowledgements

The authors are supported by Grants from the National Institute of Health (Grant No.: R01NS045883; BF), the National Multiple Sclerosis Society (Grant No.: RG-1506-04546; BF) and the Commonwealth Health Research Board (Grant No.: 236-04-17 BF).

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no potential conflicts.

References

  1. 1.
    Kawamoto EM, Vivar C, Camandola S (2012) Physiology and pathology of calcium signaling in the brain. Front Pharmacol 3:61.  https://doi.org/10.3389/fphar.2012.00061 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Brini M, Calì T, Ottolini D, Carafoli E (2014) Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci 71:2787–2814.  https://doi.org/10.1007/s00018-013-1550-7 CrossRefPubMedGoogle Scholar
  3. 3.
    Horigane S-I, Ozawa Y, Yamada H, Takemoto-Kimura S (2019) Calcium signalling: a key regulator of neuronal migration. J Biochem 165:401–409.  https://doi.org/10.1093/jb/mvz012 CrossRefPubMedGoogle Scholar
  4. 4.
    Toth AB, Shum AK, Prakriya M (2016) Regulation of neurogenesis by calcium signaling. Cell Calcium 59:124–134.  https://doi.org/10.1016/j.ceca.2016.02.011 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Shigetomi E, Patel S, Khakh BS (2016) Probing the complexities of astrocyte calcium signaling. Trends Cell Biol 26:300–312.  https://doi.org/10.1016/j.tcb.2016.01.003 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Verkhratsky A, Untiet V, Rose CR (2019) Ionic signalling in astroglia beyond calcium. J Physiol.  https://doi.org/10.1113/JP277478 CrossRefPubMedGoogle Scholar
  7. 7.
    Färber K, Kettenmann H (2006) Functional role of calcium signals for microglial function. Glia 54:656–665.  https://doi.org/10.1002/glia.20412 CrossRefPubMedGoogle Scholar
  8. 8.
    Brawek B, Garaschuk O (2013) Microglial calcium signaling in the adult, aged and diseased brain. Cell Calcium 53:159–169.  https://doi.org/10.1016/j.ceca.2012.12.003 CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang M, Liu Y, Wu S, Zhao X (2019) Ca2+ Signaling in oligodendrocyte development. Cell Mol Neurobiol 39:1071–1080.  https://doi.org/10.1007/s10571-019-00705-4 CrossRefPubMedGoogle Scholar
  10. 10.
    Pitman KA, Young KM (2016) Activity-dependent calcium signalling in oligodendrocyte generation. Int J Biochem Cell Biol 77:30–34.  https://doi.org/10.1016/j.biocel.2016.05.018 CrossRefPubMedGoogle Scholar
  11. 11.
    Butt AM (2006) Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54:666–675.  https://doi.org/10.1002/glia.20424 CrossRefPubMedGoogle Scholar
  12. 12.
    Soliven B (2001) Calcium signalling in cells of oligodendroglial lineage. Microsc Res Tech 15:672–679CrossRefGoogle Scholar
  13. 13.
    Cheli VT, Santiago González DA, Spreuer V, Paez PM (2015) Voltage-gated Ca++ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro. Exp Neurol 265:69–83.  https://doi.org/10.1016/j.expneurol.2014.12.012 CrossRefPubMedGoogle Scholar
  14. 14.
    Burgoyne RD, Helassa N, McCue HV, Haynes LP (2019) Calcium sensors in neuronal function and dysfunction. Cold Spring Harb Perspect Biol.  https://doi.org/10.1101/cshperspect.a035154 CrossRefPubMedGoogle Scholar
  15. 15.
    Schrank S, Barrington N, Stutzmann GE (2019) Calcium-handling defects and neurodegenerative disease. Cold Spring Harb Perspect Biol.  https://doi.org/10.1101/cshperspect.a035212 CrossRefPubMedGoogle Scholar
  16. 16.
    Berridge MJ (2014) Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia. Cell Tissue Res 357:477–492.  https://doi.org/10.1007/s00441-014-1806-z CrossRefPubMedGoogle Scholar
  17. 17.
    Shigetomi E, Saito K, Sano F, Koizumi S (2019) Aberrant CalciuASN Neuro m signals in reactive astrocytes: a key process in neurological disorders. Int J Mol Sci.  https://doi.org/10.3390/ijms20040996 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Verkhratsky A, Rodríguez-Arellano JJ, Parpura V, Zorec R (2017) Astroglial calcium signalling in Alzheimer’s disease. Biochem Biophys Res Commun 483:1005–1012.  https://doi.org/10.1016/j.bbrc.2016.08.088 CrossRefPubMedGoogle Scholar
  19. 19.
    Nedergaard M, Rodríguez JJ, Verkhratsky A (2010) Glial calcium and diseases of the nervous system. Cell Calcium 47:140–149.  https://doi.org/10.1016/j.ceca.2009.11.010 CrossRefPubMedGoogle Scholar
  20. 20.
    Blaustein MP, Lederer WJ (1999) Sodium/calcium exchange: its physiological implications. Physiol Rev 79:763–854CrossRefGoogle Scholar
  21. 21.
    DiPolo Reinaldo, Beauge L (1987) Plasma membrane mechanisms for intracellular calcium regulation in squid axons. Acta Physiol Pharmacol Latinoam 37:437–444PubMedGoogle Scholar
  22. 22.
    Khananshvili D (1990) Distinction between the two basic mechanisms of cation transport in the cardiac Na(+)-Ca2+ exchange system. Biochemistry 29:2437–2442.  https://doi.org/10.1021/bi00462a001 CrossRefPubMedGoogle Scholar
  23. 23.
    Reeves JP, Condrescu M, Chernaya G, Gardner JP (1994) Na+/Ca2+ antiport in the mammalian heart. J Exp Biol 196:375–388PubMedGoogle Scholar
  24. 24.
    Baker PF, Blaustein MP, Hodgkin AL, Steinhardt RA (1969) The influence of calcium on sodium efflux in squid axons. J Physiol 200:431–458.  https://doi.org/10.1113/jphysiol.1969.sp008702 CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Reyes RC, Verkhratsky A, Parpura V (2012) Plasmalemmal Na+/Ca2+ exchanger modulates Ca2+-dependent exocytotic release of glutamate from rat cortical astrocytes. ASN Neuro.  https://doi.org/10.1042/AN20110059 CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Parpura V, Sekler I, Fern R (2016) Plasmalemmal and mitochondrial Na(+) -Ca(2 +) exchange in neuroglia. Glia 64:1646–1654.  https://doi.org/10.1002/glia.22975 CrossRefPubMedGoogle Scholar
  27. 27.
    Roome CJ, Power EM, Empson RM (2013) Transient reversal of the sodium/calcium exchanger boosts presynaptic calcium and synaptic transmission at a cerebellar synapse. J Neurophysiol 109:1669–1680.  https://doi.org/10.1152/jn.00854.2012 CrossRefPubMedGoogle Scholar
  28. 28.
    Jeon D, Yang Y-M, Jeong M-J et al (2003) Enhanced learning and memory in mice lacking Na+/Ca2+ exchanger 2. Neuron 38:965–976.  https://doi.org/10.1016/s0896-6273(03)00334-9 CrossRefPubMedGoogle Scholar
  29. 29.
    Molinaro P, Viggiano D, Nisticò R et al (2011) Na+–Ca2+ exchanger (NCX3) knock-out mice display an impairment in hippocampal long-term potentiation and spatial learning and memory. J Neurosci 31:7312–7321.  https://doi.org/10.1523/JNEUROSCI.6296-10.2011 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Molinaro P, Cuomo O, Pignataro G et al (2008) Targeted disruption of Na+/Ca2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage. J Neurosci 28:1179–1184.  https://doi.org/10.1523/JNEUROSCI.4671-07.2008 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Pignataro G, Sirabella R, Anzilotti S et al (2014) Does Na+/Ca2+ exchanger, NCX, represent a new druggable target in stroke intervention? Transl Stroke Res 5:145–155.  https://doi.org/10.1007/s12975-013-0308-8 CrossRefPubMedGoogle Scholar
  32. 32.
    Jeffs GJ, Meloni BP, Sokolow S et al (2008) NCX3 knockout mice exhibit increased hippocampal CA1 and CA2 neuronal damage compared to wild-type mice following global cerebral ischemia. Exp Neurol 210:268–273.  https://doi.org/10.1016/j.expneurol.2007.10.013 CrossRefPubMedGoogle Scholar
  33. 33.
    Sirabella R, Sisalli MJ, Costa G et al (2018) NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson’s Disease. Cell Death Dis 9:725.  https://doi.org/10.1038/s41419-018-0775-7 CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Takuma K, Ago Y, Matsuda T (2013) The glial sodium-calcium exchanger: a new target for nitric oxide-mediated cellular toxicity. Curr Protein Pept Sci 14:43–50CrossRefGoogle Scholar
  35. 35.
    Noda M, Ifuku M, Mori Y, Verkhratsky A (2013) Calcium influx through reversed NCX controls migration of microglia. Advances in experimental medicine and biology. Springer, Boston, pp 289–294Google Scholar
  36. 36.
    Boscia F, Gala R, Pannaccione A et al (2009) NCX1 expression and functional activity increase in microglia invading the infarct core. Stroke 40:3608–3617.  https://doi.org/10.1161/STROKEAHA.109.557439 CrossRefPubMedGoogle Scholar
  37. 37.
    Khananshvili D (2013) The SLC8 gene family of sodium-calcium exchangers (NCX)—structure, function, and regulation in health and disease. Mol Aspects Med 34:220–235.  https://doi.org/10.1016/j.mam.2012.07.003 CrossRefPubMedGoogle Scholar
  38. 38.
    Lytton J (2007) Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. Biochem J 406:365–382.  https://doi.org/10.1042/BJ20070619 CrossRefPubMedGoogle Scholar
  39. 39.
    Carafoli E (1987) Intracellular calcium homeostasis. Annu Rev Biochem 56:395–433.  https://doi.org/10.1146/annurev.bi.56.070187.002143 CrossRefPubMedGoogle Scholar
  40. 40.
    Philipson KD, Nicoll DA (2000) Sodium–calcium exchanger: a molecular perspective. Annu Rev Physiol 62:111–133.  https://doi.org/10.1146/annurev.physiol.62.1.111 CrossRefPubMedGoogle Scholar
  41. 41.
    Nicoll D, Longoni S, Philipson K (1990) Molecular cloning and functional expression of the cardiac sarcolemmal Na(+)-Ca2 + exchanger. Science 250:562–565.  https://doi.org/10.1126/science.1700476 CrossRefPubMedGoogle Scholar
  42. 42.
    Li Z, Matsuokas S, Hryshkob LV et al (1994) Cloning of the NCX2 isoform of the plasma membrane Na+–Ca2+ exchanger. J Biol Chem 269:17434–17439PubMedGoogle Scholar
  43. 43.
    Nicoll DA, Quednau BD, Qui Z et al (1996) Cloning of a third mammalian Na+–Ca2+ exchanger, NCX3. J Biol Chem 271:24914–24921.  https://doi.org/10.1074/jbc.271.40.24914 CrossRefPubMedGoogle Scholar
  44. 44.
    On C, Marshall CR, Perry SF et al (2009) Characterization of zebrafish (Danio rerio) NCX4: a novel NCX with distinct electrophysiological properties. Am J Physiol Physiol 296:C173–C181.  https://doi.org/10.1152/ajpcell.00455.2008 CrossRefGoogle Scholar
  45. 45.
    On C, Marshall CR, Chen N et al (2008) Gene structure evolution of the Na+–Ca2+ exchanger (NCX) family. BMC Evol Biol 8:127.  https://doi.org/10.1186/1471-2148-8-127 CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Marshall CR, Fox JA, Butland SL et al (2005) Phylogeny of Na +/Ca2 + exchanger (NCX) genes from genomic data identifies new gene duplications and a new family member in fish species. Physiol Genomics 21:161–173.  https://doi.org/10.1152/physiolgenomics.00286.2004 CrossRefPubMedGoogle Scholar
  47. 47.
    Boyman L, Williams GSB, Khananshvili D et al (2013) NCLX: the mitochondrial sodium calcium exchanger. J Mol Cell Cardiol 59:205–213CrossRefGoogle Scholar
  48. 48.
    Palty R, Silverman WF, Hershfinkel M et al (2010) NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci USA 107:436–441.  https://doi.org/10.1073/pnas.0908099107 CrossRefPubMedGoogle Scholar
  49. 49.
    Palty R, Sekler I (2012) The mitochondrial Na+/Ca2+ exchanger. Cell Calcium 52:9–15CrossRefGoogle Scholar
  50. 50.
    Linck B, Qiu Z, He Z et al (1998) Functional comparison of the three isoforms of the Na+/Ca2+ exchanger (NCX1, NCX2, NCX3). Am J Physiol 274:C415–C423.  https://doi.org/10.1152/ajpcell.1998.274.2.C415 CrossRefPubMedGoogle Scholar
  51. 51.
    Ren X, Philipson KD (2013) The topology of the cardiac Na+/Ca2+ exchanger, NCX1. J Mol Cell Cardiol 57:68–71.  https://doi.org/10.1016/j.yjmcc.2013.01.010 CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Liao J, Li H, Zeng W et al (2012) Structural insight into the ion-exchange mechanism of the sodium/calcium exchanger. Science 335:686–690.  https://doi.org/10.1126/science.1215759 CrossRefPubMedGoogle Scholar
  53. 53.
    Liao J, Marinelli F, Lee C et al (2016) Mechanism of extracellular ion exchange and binding-site occlusion in a sodium/calcium exchanger. Nat Struct Mol Biol 23:590–599.  https://doi.org/10.1038/nsmb.3230 CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Giladi M, Shor R, Lisnyansky M, Khananshvili D (2016) Structure-functional basis of ion transport in sodium–calcium exchanger (NCX) proteins. Int J Mol Sci 17:1949.  https://doi.org/10.3390/ijms17111949 CrossRefPubMedCentralGoogle Scholar
  55. 55.
    Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature 211:969–970.  https://doi.org/10.1038/211969a0 CrossRefPubMedGoogle Scholar
  56. 56.
    Forrest LR, Krämer R, Ziegler C (2011) The structural basis of secondary active transport mechanisms. Biochim Biophys Acta 1807:167–188.  https://doi.org/10.1016/j.bbabio.2010.10.014 CrossRefPubMedGoogle Scholar
  57. 57.
    Khananshvili D (2014) Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions. Pflugers Arch 466:43–60.  https://doi.org/10.1007/s00424-013-1405-y CrossRefPubMedGoogle Scholar
  58. 58.
    Giladi M, Hiller R, Hirsch JA, Khananshvili D (2013) Population shift underlies Ca2+-induced regulatory transitions in the sodium-calcium exchanger (NCX). J Biol Chem 288:23141–23149.  https://doi.org/10.1074/jbc.M113.471698 CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Ottolia M, Nicoll DA, John S, Philipson KD (2010) Interactions between Ca2+ binding domains of the Na+–Ca2+ exchanger and secondary regulation. Channels 4:159–162.  https://doi.org/10.4161/chan.4.3.11386 CrossRefPubMedGoogle Scholar
  60. 60.
    Giladi M, Lee SY, Ariely Y et al (2017) Structure-based dynamic arrays in regulatory domains of sodium-calcium exchanger (NCX) isoforms. Sci Rep 7:993.  https://doi.org/10.1038/s41598-017-01102-x CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Hilge M, Aelen J, Vuister GW (2006) Ca2+ regulation in the Na+/Ca2+ exchanger involves two markedly different Ca2+ sensors. Mol Cell 22:15–25.  https://doi.org/10.1016/j.molcel.2006.03.008 CrossRefPubMedGoogle Scholar
  62. 62.
    Besserer GM, Ottolia M, Nicoll DA et al (2007) The second Ca2 + -binding domain of the Na + -Ca 2 + exchanger is essential for regulation: crystal structures and mutational analysis. Proc Natl Acad Sci U S A 104:18467–18472.  https://doi.org/10.1073/pnas.0707417104 CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Hilgemann DW, Matsuoka S, Nagel GA, Collins A (1992) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol 100:905–932.  https://doi.org/10.1085/jgp.100.6.905 CrossRefPubMedGoogle Scholar
  64. 64.
    Hilge M (2013) Ca(2 +) regulation in the Na(+)/Ca (2 +) exchanger features a dual electrostatic switch mechanism. Adv Exp Med Biol 961:27–33.  https://doi.org/10.1007/978-1-4614-4756-6_3 CrossRefPubMedGoogle Scholar
  65. 65.
    Hilge M (2012) Ca2+ regulation of ion transport in the Na+/Ca2+ exchanger. J Biol Chem 287:31641–31649.  https://doi.org/10.1074/jbc.R112.353573 CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Tal I, Kozlovsky T, Brisker D et al (2016) Kinetic and equilibrium properties of regulatory Ca2 + -binding domains in sodium–calcium exchangers 2 and 3. Cell Calcium 59:181–188.  https://doi.org/10.1016/J.CECA.2016.01.008 CrossRefPubMedGoogle Scholar
  67. 67.
    Steinman L, Altmann D, Sansom D et al (1996) Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299–302.  https://doi.org/10.1016/S0092-8674(00)81107-1 CrossRefPubMedGoogle Scholar
  68. 68.
    Lee SY, Giladi M, Bohbot H et al (2016) Structure-dynamic basis of splicing-dependent regulation in tissue-specific variants of the sodium-calcium exchanger. FASEB J 30:1356–1366.  https://doi.org/10.1096/fj.15-282251 CrossRefPubMedGoogle Scholar
  69. 69.
    Giladi M, Bohbot H, Buki T et al (2012) Dynamic features of allosteric Ca2+ sensor in tissue-specific NCX variants. Cell Calcium 51:478–485.  https://doi.org/10.1016/j.ceca.2012.04.007 CrossRefPubMedGoogle Scholar
  70. 70.
    Matsuoka S, Nicoll DA, He Z, Philipson KD (1997) Regulation of cardiac Na(+)-Ca2+ exchanger by the endogenous XIP region. J Gen Physiol 109:273–286.  https://doi.org/10.1085/jgp.109.2.273 CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Li Z, Nicoll DA, Collins A et al (1991) Identification of a peptide inhibitor of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. J Biol Chem 266:1014–1020PubMedGoogle Scholar
  72. 72.
    Giladi M, Tal I, Khananshvili D (2016) Structural Features of Ion Transport and Allosteric Regulation in Sodium-Calcium Exchanger (NCX) Proteins. Front Physiol 7:30.  https://doi.org/10.3389/fphys.2016.00030 CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Hilgemann DW, Collins A, Matsuoka S (1992) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol 100:933–961.  https://doi.org/10.1085/jgp.100.6.933 CrossRefPubMedGoogle Scholar
  74. 74.
    Chernysh O, Condrescu M, Reeves JP (2008) Sodium-dependent inactivation of sodium/calcium exchange in transfected Chinese hamster ovary cells. Am J Physiol Cell Physiol 295:C872–C882.  https://doi.org/10.1152/ajpcell.00221.2008 CrossRefPubMedPubMedCentralGoogle Scholar
  75. 75.
    Verkhratsky A, Trebak M, Perocchi F et al (2018) Crosslink between calcium and sodium signalling. Exp Physiol 103:157–169.  https://doi.org/10.1113/EP086534 CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Michel LYM, Verkaart S, Koopman WJH et al (2014) Function and regulation of the Na+–Ca2+ exchanger NCX3 splice variants in brain and skeletal muscle. J Biol Chem 289:11293–11303.  https://doi.org/10.1074/jbc.M113.529388 CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    DiPolo R, Beaugé L (2006) Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions. Physiol Rev 86:155–203CrossRefGoogle Scholar
  78. 78.
    Berberián G, Bollo M, Montich G et al (2009) A novel lipid binding protein is a factor required for MgATP stimulation of the squid nerve Na+/Ca2+ exchanger. Biochim Biophys Acta 1788:1255–1262.  https://doi.org/10.1016/j.bbamem.2008.12.016 CrossRefPubMedGoogle Scholar
  79. 79.
    Cousido-Siah A, Ayoub D, Berberián G et al (2012) Structural and functional studies of ReP1-NCXSQ, a protein regulating the squid nerve Na+/Ca2+ exchanger. Acta Crystallogr D 68:1098–1107.  https://doi.org/10.1107/S090744491202094X CrossRefPubMedGoogle Scholar
  80. 80.
    Lariccia V, Amoroso S (2018) Calcium- and ATP-dependent regulation of Na/Ca exchange function in BHK cells: comparison of NCX1 and NCX3 exchangers. Cell Calcium 73:95–103.  https://doi.org/10.1016/j.ceca.2018.04.007 CrossRefPubMedGoogle Scholar
  81. 81.
    Dyck C, Omelchenko A, Elias CL et al (1999) Ionic regulatory properties of brain and kidney splice variants of the NCX1 Na-Ca 2 exchanger. J Gen Physiol 114:701–711.  https://doi.org/10.1085/jgp.114.5.701 CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Matsuoka S (2004) Forefront of Na+/Ca2+ exchanger studies: regulation kinetics of Na+/Ca2+ exchangers. J Pharmacol Sci 96:12–14.  https://doi.org/10.1254/jphs.fmj04002x2 CrossRefPubMedGoogle Scholar
  83. 83.
    Quednau BD, Nicoll D, Philipson KD (1997) Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCXl, NCX2, and NCX3 in rat. Am J Physiol 272:C1250–C1261.  https://doi.org/10.1152/ajpcell.1997.272.4.C1250 CrossRefPubMedGoogle Scholar
  84. 84.
    Nakasaki Y, Iwamoto T, Hanada H et al (1993) Cloning of the rat aortic smooth muscle Na +/Ca2 + exchanger and tissue-specific expression of isoforms1. J Biochem 114:528–534.  https://doi.org/10.1093/oxfordjournals.jbchem.a124211 CrossRefPubMedGoogle Scholar
  85. 85.
    Rose CR, Ransom BR (1996) Mechanisms of H+ and Na+ changes induced by glutamate, kainate, and D-aspartate in rat hippocampal astrocytes. J Neurosci 16:5393–5404CrossRefGoogle Scholar
  86. 86.
    Nicholas SB, Yang W, Lee SL et al (1998) Alternative promoters and cardiac muscle cell-specific expression of the Na+/Ca2+ exchanger gene. Am J Physiol 274:H217–H232.  https://doi.org/10.1152/ajpheart.1998.274.1.H217 CrossRefPubMedGoogle Scholar
  87. 87.
    Barnes KV, Cheng G, Dawson MM, Menick DR (1997) Cloning of cardiac, kidney, and brain promoters of the feline ncx1 gene. J Biol Chem 272:11510–11517CrossRefGoogle Scholar
  88. 88.
    Koban MU, Brugh SA, Riordon DR et al (2001) A distant upstream region of the rat multipartite Na(+)-Ca(2+) exchanger NCX1 gene promoter is sufficient to confer cardiac-specific expression. Mech Dev 109:267–279.  https://doi.org/10.1016/s0925-4773(01)00548-2 CrossRefPubMedGoogle Scholar
  89. 89.
    Lee S-L, Yu ASL, Lytton J (1994) Tissue-specific Expression of Na + -Ca2 + exchanger Isoforms. J Biol Chem 269:14849–14852PubMedGoogle Scholar
  90. 90.
    Yu X-M, Groveman BR, Fang X-Q, Lin S-X (2010) The role of intracellular sodium (Na+) in the regulation of calcium (Ca2+)-mediated signaling and toxicity. Health (Irvine Calif) 02:8–15.  https://doi.org/10.4236/health.2010.21002 CrossRefGoogle Scholar
  91. 91.
    Stadelmann C, Timmler S, Barrantes-Freer A, Simons M (2019) Myelin in the Central Nervous System: structure, Function, and Pathology. Physiol Rev 99:1381–1431.  https://doi.org/10.1152/physrev.00031.2018 CrossRefPubMedGoogle Scholar
  92. 92.
    Pfeiffer S, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191–197.  https://doi.org/10.1016/0962-8924(93)90213-K CrossRefPubMedGoogle Scholar
  93. 93.
    Michalski JP, Kothary R (2015) Oligodendrocytes in a nutshell. Front Cell Neurosci 9:340.  https://doi.org/10.3389/fncel.2015.00340 CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Elbaz B, Popko B (2019) Molecular control of oligodendrocyte development. Trends Neurosci 42:263–277.  https://doi.org/10.1016/j.tins.2019.01.002 CrossRefPubMedGoogle Scholar
  95. 95.
    Tiane A, Schepers M, Rombaut B et al (2019) From OPC to oligodendrocyte: an epigenetic journey. Cells.  https://doi.org/10.3390/cells8101236 CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Sock E, Wegner M (2019) Transcriptional control of myelination and remyelination. Glia 67:2153–2165.  https://doi.org/10.1002/glia.23636 CrossRefPubMedGoogle Scholar
  97. 97.
    Wheeler NA, Fuss B (2016) Extracellular cues influencing oligodendrocyte differentiation and (re)myelination. Exp Neurol 283:512–530.  https://doi.org/10.1016/j.expneurol.2016.03.019 CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Yu L, Colvin RA (1997) Regional differences in expression of transcripts for Na+/Ca2+ exchanger isoforms in rat brain. Mol Brain Res 50:285–292.  https://doi.org/10.1016/S0169-328X(97)00202-7 CrossRefPubMedGoogle Scholar
  99. 99.
    Tong XP, Li XY, Zhou B et al (2009) Ca2 + signaling evoked by activation of Na + channels and Na +/Ca2 + exchangers is required for GABA-induced NG2 cell migration. J Cell Biol 186:113–128.  https://doi.org/10.1083/jcb.200811071 CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Steffensen I, Waxman SG, Mills L, Stys PK (1997) Immunolocalization of the Na+-Ca2+ exchanger in mammalian myelinated axons. Brain Res 776:1–9.  https://doi.org/10.1016/S0006-8993(97)00868-8 CrossRefPubMedGoogle Scholar
  101. 101.
    Boscia F, D’avanzo C, Pannaccione A et al (2012) Silencing or knocking out the Na +/Ca2 + exchanger-3 (NCX3) impairs oligodendrocyte differentiation. Cell Death Differ 19:562–572.  https://doi.org/10.1038/cdd.2011.125 CrossRefPubMedGoogle Scholar
  102. 102.
    Boscia F, D’Avanzo C, Pannaccione A et al (2013) New roles of NCX in glial cells: activation of microglia in ischemia and differentiation of oligodendrocytes. Adv Exp Med Biol 961:307–316.  https://doi.org/10.1007/978-1-4614-4756-6_26 CrossRefPubMedGoogle Scholar
  103. 103.
    Simpson PB, Armstrong RC (1999) Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration. Glia 26:22–35CrossRefGoogle Scholar
  104. 104.
    Paez PM, Fulton D, Colwell CS, Campagnoni AT (2009) Voltage-operated Ca2+ and Na+ channels in the oligodendrocyte lineage. J Neurosci Res 87:3259–3266.  https://doi.org/10.1002/jnr.21938 CrossRefPubMedGoogle Scholar
  105. 105.
    Habermacher C, Angulo MC, Benamer N (2019) Glutamate versus GABA in neuron-oligodendroglia communication. Glia 67:2092–2106.  https://doi.org/10.1002/glia.23618 CrossRefPubMedGoogle Scholar
  106. 106.
    Friess M, Hammann J, Unichenko P et al (2016) Intracellular ion signaling influences myelin basic protein synthesis in oligodendrocyte precursor cells. Cell Calcium 60:322–330.  https://doi.org/10.1016/j.ceca.2016.06.009 CrossRefPubMedGoogle Scholar
  107. 107.
    Hammann J, Bassetti D, White R et al (2018) α2 isoform of Na+, K+-ATPase via Na+, Ca2+ exchanger modulates myelin basic protein synthesis in oligodendrocyte lineage cells in vitro. Cell Calcium 73:1–10.  https://doi.org/10.1016/j.ceca.2018.03.003 CrossRefPubMedGoogle Scholar
  108. 108.
    Thakurela S, Garding A, Jung RB et al (2016) The transcriptome of mouse central nervous system myelin. Sci Rep 6:25828.  https://doi.org/10.1038/srep25828 CrossRefPubMedPubMedCentralGoogle Scholar
  109. 109.
    Martinez-Lozada Z, Waggener CT, Kim K et al (2014) Activation of sodium-dependent glutamate transporters regulates the morphological aspects of oligodendrocyte maturation via signaling through calcium/calmodulin-dependent kinase IIβ’s actin-binding/-stabilizing domain. Glia 62:1543–1558.  https://doi.org/10.1002/glia.22699 CrossRefPubMedPubMedCentralGoogle Scholar
  110. 110.
    Suárez-Pozos E, Thomason EJ, Fuss B (2019) Glutamate transporters: expression and function in oligodendrocytes. Neurochem Res.  https://doi.org/10.1007/s11064-018-02708-x CrossRefPubMedGoogle Scholar
  111. 111.
    Martínez-Lozada Z, Hernández-Kelly LC, Aguilera J et al (2011) Signaling through EAAT-1/GLAST in cultured Bergmann glia cells. Neurochem Int 59:871–879.  https://doi.org/10.1016/j.neuint.2011.07.015 CrossRefPubMedGoogle Scholar
  112. 112.
    Iwamoto T, Kita S, Shigekawa M (2002) Functional analysis of Na+/Ca2+ exchanger using novel drugs and genetically engineered mice. Nihon Yakurigaku Zasshi 120:91P–93PCrossRefGoogle Scholar
  113. 113.
    Iwamoto T, Inoue Y, Ito K et al (2004) The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]- thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Mol Pharmacol 66:45–55.  https://doi.org/10.1124/mol.66.1.45 CrossRefPubMedGoogle Scholar
  114. 114.
    Gong XQ, Frandsen A, Lu WY et al (2005) D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons. Br J Pharmacol 145:449–459.  https://doi.org/10.1038/sj.bjp.0706199 CrossRefPubMedPubMedCentralGoogle Scholar
  115. 115.
    Sugiyama H, Ito I, Watanabe M (1989) Glutamate receptor subtypes may be classified into two major categories: a study on Xenopus oocytes injected with rat brain mRNA. Neuron 3:129–132.  https://doi.org/10.1016/0896-6273(89)90121-9 CrossRefPubMedGoogle Scholar
  116. 116.
    Bender AS, Woodbury DM, White HS (1997) The rapid L- and D-aspartate uptake in cultured astrocytes. Neurochem Res 22:721–726.  https://doi.org/10.1023/a:1027358211472 CrossRefPubMedGoogle Scholar
  117. 117.
    de Rosa V, Secondo A, Pannaccione A et al (2019) d-Aspartate treatment attenuates myelin damage and stimulates myelin repair. EMBO Mol Med 11:e9278.  https://doi.org/10.15252/emmm.201809278 CrossRefPubMedGoogle Scholar
  118. 118.
    Kukley M, Capetillo-Zarate E, Dietrich D (2007) Vesicular glutamate release from axons in white matter. Nat Neurosci 10:311–320.  https://doi.org/10.1038/nn1850 CrossRefPubMedGoogle Scholar
  119. 119.
    Ziskin JL, Nishiyama A, Rubio M et al (2007) Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10:321–330.  https://doi.org/10.1038/nn1854 CrossRefPubMedPubMedCentralGoogle Scholar
  120. 120.
    Wake H, Lee PR, Fields RD (2011) Control of local protein synthesis…background. Science 333:1647–1652.  https://doi.org/10.1126/science.1206998 CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    Foster AY, Bujalka H, Emery B (2019) Axoglial interactions in myelin plasticity: evaluating the relationship between neuronal activity and oligodendrocyte dynamics. Glia 67:2038–2049.  https://doi.org/10.1002/glia.23629 CrossRefPubMedGoogle Scholar
  122. 122.
    Monje M (2018) Myelin plasticity and nervous system function. Annu Rev Neurosci 41:61–76.  https://doi.org/10.1146/annurev-neuro-080317-061853 CrossRefPubMedGoogle Scholar
  123. 123.
    Chorghay Z, Káradóttir RT, Ruthazer ES (2018) White matter plasticity keeps the brain in tune: axons conduct while glia wrap. Front Cell Neurosci 12:428.  https://doi.org/10.3389/fncel.2018.00428 CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Bechler ME, Swire M, Ffrench-Constant C (2018) Intrinsic and adaptive myelination-A sequential mechanism for smart wiring in the brain. Dev Neurobiol 78:68–79.  https://doi.org/10.1002/dneu.22518 CrossRefPubMedGoogle Scholar
  125. 125.
    Back SA, Luo NL, Borenstein NS et al (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 21:1302–1312.  https://doi.org/10.1523/jneurosci.21-04-01302.2001 CrossRefPubMedPubMedCentralGoogle Scholar
  126. 126.
    Cai Q, Ma T, Tian Y et al (2018) Catalpol inhibits ischemia-induced premyelinating oligodendrocyte damage through regulation of intercellular calcium homeostasis via Na+/Ca2+ exchanger 3. Int J Mol Sci.  https://doi.org/10.3390/ijms19071925 CrossRefPubMedPubMedCentralGoogle Scholar
  127. 127.
    Ma T, Wu X, Cai Q et al (2015) Lead poisoning disturbs oligodendrocytes differentiation involved in decreased expression of NCX3 inducing intracellular calcium overload. Int J Mol Sci 16:19096–19110.  https://doi.org/10.3390/ijms160819096 CrossRefPubMedPubMedCentralGoogle Scholar
  128. 128.
    Deng W, McKinnon RD, Poretz RD (2001) Lead exposure delays the differentiation of oligodendroglial progenitors in vitro. Toxicol Appl Pharmacol 174:235–244.  https://doi.org/10.1006/TAAP.2001.9219 CrossRefPubMedGoogle Scholar
  129. 129.
    Pignataro G, Cuomo O, Vinciguerra A et al (2013) NCX as a key player in the neuroprotection exerted by ischemic preconditioning and postconditioning. Adv Exp Med Miol 961:223–240.  https://doi.org/10.1007/978-1-4614-4756-6_19 CrossRefGoogle Scholar
  130. 130.
    Pignataro G, Gala R, Cuomo O et al (2004) Two sodium/calcium exchanger gene products, NCX1 and NCX3, play a major role in the development of permanent focal cerebral ischemia. Stroke 35:2566–2570.  https://doi.org/10.1161/01.STR.0000143730.29964.93 CrossRefPubMedGoogle Scholar
  131. 131.
    Gerkau NJ, Rakers C, Durry S et al (2018) Reverse NCX attenuates cellular sodium loading in metabolically compromised cortex. Cereb Cortex 28:4264–4280.  https://doi.org/10.1093/cercor/bhx280 CrossRefPubMedGoogle Scholar
  132. 132.
    Chen H, Kintner DB, Jones M et al (2007) AMPA-mediated excitotoxicity in oligodendrocytes: role for Na+-K+-Cl—co-transport and reversal of Na+/Ca2+ exchanger. J Neurochem 102:1783–1795.  https://doi.org/10.1111/j.1471-4159.2007.04638.x CrossRefPubMedGoogle Scholar
  133. 133.
    Stover JF, Pleines UE, Morganti-Kossmann MC et al (1997) Neurotransmitters in cerebrospinal fluid reflect pathological activity. Eur J Clin Invest 27:1038–1043.  https://doi.org/10.1046/j.1365-2362.1997.2250774.x CrossRefPubMedGoogle Scholar
  134. 134.
    Macrez R, Stys PK, Vivien D et al (2016) Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunities. Lancet Neurol 15:1089–1102.  https://doi.org/10.1016/S1474-4422(16)30165-X CrossRefPubMedGoogle Scholar
  135. 135.
    Newcombe J, Uddin A, Dove R et al (2008) Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18:52–61.  https://doi.org/10.1111/j.1750-3639.2007.00101.x CrossRefPubMedGoogle Scholar
  136. 136.
    Follett PL, Deng W, Dai W et al (2004) Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 24:4412–4420.  https://doi.org/10.1523/JNEUROSCI.0477-04.2004 CrossRefPubMedPubMedCentralGoogle Scholar
  137. 137.
    McCracken E, Fowler JH, Dewar D et al (2002) Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 22:1090–1097.  https://doi.org/10.1097/00004647-200209000-00006 CrossRefPubMedGoogle Scholar
  138. 138.
    Park E, Velumian AA, Fehlings MG (2004) The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 21:754–774.  https://doi.org/10.1089/0897715041269641 CrossRefPubMedGoogle Scholar
  139. 139.
    Rosenberg LJ, Teng YD, Wrathall JR (1999) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J Neurosci 19:464–475CrossRefGoogle Scholar
  140. 140.
    Wosik K, Ruffini F, Almazan G et al (2004) Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain 127:2636–2648.  https://doi.org/10.1093/brain/awh302 CrossRefPubMedGoogle Scholar
  141. 141.
    Itoh T, Beesley J, Itoh A et al (2002) AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem 81:390–402.  https://doi.org/10.1046/j.1471-4159.2002.00866.x CrossRefPubMedGoogle Scholar
  142. 142.
    Ceprian M, Fulton D (2019) Glial cell AMPA receptors in nervous system health, injury and disease. Int J Mol Sci.  https://doi.org/10.3390/ijms20102450 CrossRefPubMedPubMedCentralGoogle Scholar
  143. 143.
    Fan X, Xiong Y, Wang Y (2019) A reignited debate over the cell(s) of origin for glioblastoma and its clinical implications. Front Med 13:531–539.  https://doi.org/10.1007/s11684-019-0700-1 CrossRefPubMedGoogle Scholar
  144. 144.
    Hsu LS, Chou WY, Chueh SH (1995) Evidence for a Na+/Ca2+ exchanger in neuroblastoma x glioma hybrid NG108-15 cells. Biochem J 309:445–452.  https://doi.org/10.1042/bj3090445 CrossRefPubMedPubMedCentralGoogle Scholar
  145. 145.
    Amoroso S, De Maio M, Russo GM et al (1997) Pharmacological evidence that the activation of the Na(+)-Ca2+ exchanger protects C6 glioma cells during chemical hypoxia. Br J Pharmacol 121:303–309.  https://doi.org/10.1038/sj.bjp.0701092 CrossRefPubMedPubMedCentralGoogle Scholar
  146. 146.
    Rodrigues T, Estevez GNN, Tersariol ILDS (2019) Na +/Ca2 + exchangers: unexploited opportunities for cancer therapy? Biochem Pharmacol 163:357–361.  https://doi.org/10.1016/j.bcp.2019.02.032 CrossRefPubMedGoogle Scholar
  147. 147.
    Hu H-J, Wang S-S, Wang Y-X et al (2019) Blockade of the forward Na+/Ca2+ exchanger suppresses the growth of glioblastoma cells through Ca2+-mediated cell death. Br J Pharmacol 176:2691–2707.  https://doi.org/10.1111/bph.14692 CrossRefPubMedPubMedCentralGoogle Scholar
  148. 148.
    Marques S, Zeisel A, Codeluppi S et al (2016) Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352:1326–1329.  https://doi.org/10.1126/science.aaf6463 CrossRefPubMedPubMedCentralGoogle Scholar
  149. 149.
    Foerster S, Hill MFE, Franklin RJM (2019) Diversity in the oligodendrocyte lineage: plasticity or heterogeneity? Glia 67:1797–1805.  https://doi.org/10.1002/glia.23607 CrossRefPubMedGoogle Scholar
  150. 150.
    Spitzer SO, Sitnikov S, Kamen Y et al (2019) Oligodendrocyte Progenitor Cells Become Regionally Diverse and Heterogeneous with Age. Neuron 101:459.e5–471.e5.  https://doi.org/10.1016/j.neuron.2018.12.020 CrossRefGoogle Scholar
  151. 151.
    Jäkel S, Agirre E, Mendanha Falcão A et al (2019) Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature 566:543–547.  https://doi.org/10.1038/s41586-019-0903-2 CrossRefPubMedPubMedCentralGoogle Scholar
  152. 152.
    Watanabe Y (2019) Cardiac Na+/Ca2+ exchange stimulators among cardioprotective drugs. J Physiol Sci.  https://doi.org/10.1007/s12576-019-00721-5 CrossRefPubMedGoogle Scholar
  153. 153.
    Song S, Luo L, Sun B, Sun D (2019) Roles of glial ion transporters in brain diseases. Glia.  https://doi.org/10.1002/glia.23699 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of Anatomy and NeurobiologyVirginia Commonwealth University School of MedicineRichmondUSA
  2. 2.Departamento de ToxicologíaCentro de Investigación y de Estudios Avanzados del Instituto Politécnico NacionalCiudad de MéxicoMexico

Personalised recommendations